News

Matti Bergendahl to step in as new CEO at Ambea, Mehiläinen’s parent company

Time: 28.05.

Matti Bergendahl (43) has been appointed as the new President and Chief Executive Officer of Ambea AB. Bergendahl, who has been Deputy CEO of Ambea since 2007 and CEO of Mehiläinen Oy since 2005, replaces Ralph Riber who will take up new challenges outside the company. Bergendahl will also continue as CEO of the Mehiläinen Group.

Ambea is the largest private healthcare and care services group in the Nordic countries. Its subsidiary, Mehiläinen, is Finland’s best-known and most respected private healthcare and care services provider. The Ambea Group also includes Carema Healthcare and Carema Care which operate in Sweden and Norway. Earlier this year Ambea was acquired by Triton and KKR (Kohlberg Kravis Roberts & Co).

“Matti Bergendahl’s appointment will further strengthen Ambea. Bergendahl has an excellent track record in the Mehiläinen Group and we believe he is the right man to lead Ambea into a new phase of development,” says Magnus Lindquist, Chairman of Ambea’s Board of Directors.

Matti Bergendahl has had a long and diverse career in the healthcare and care industries. He has not only served the Mehiläinen Group in several management positions since 2002, including CEO since 2005, but has also served as Chairman of the Private Healthcare Association (a member of the Confederation of Finnish Industries EK), and as a member of the boards of EK’s central organisation, the Service Sectors’ Association and the Healthcare Services Companies’ Association. Bergendahl graduated with MD and MBA degrees and is a docent and specialist in paediatric care.

“As the leading Nordic healthcare and care group, Ambea is in an extremely interesting phase of development and I look forward to my work as CEO with a good deal of optimism. In developing Mehiläinen and Ambea I will also have the support of a very committed and professional team of managers and staff,” says Matti Bergendahl.

For additional information, please contact:

Matti Bergendahl, CEO of Mehiläinen Oy, CEO of Ambea AB, tel. +358 40 833 54 61
Magnus Lindquist, Chairman of the Board of Ambea AB

The Mehiläinen Group is the best-known and top-rated provider of private healthcare and social services in Finland. Mehiläinen’s nationwide network offers a wide portfolio of social and healthcare services for private, corporate and municipal customers. The company was established in 1909 and has about 1700 employees and 1900 physicians. In 2009, the Mehiläinen Group posted turnover of EUR 167 million. Mehiläinen is part of the Nordic healthcare group Ambea, one of the largest providers of health and nursing services in Europe.

Ambea brings together a broad spectrum of competencies in both private and publicly financed healthcare and care services. Operations are conducted in Sweden, Norway and Finland through the subsidiaries Carema Care, Carema Healthcare and Mehiläinen. With 600 units, Ambea is one of the largest healthcare and care services companies in the Nordic region. Ambea’s vision is to be the first choice in the market by developing quality and innovative healthcare and care services. The Group has annual sales of more than SEK 7 billion and approximately 10,300 full-time employees. For additional information, please visit Ambea's website at www.ambea.com